R&D Views & Analysis | pharmaphorum

Views & Analysis

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

R&D

Exploring the future: Opportunities and challenges in cell a...

Rare disease treatment poses distinct challenges for physicians, patients, caregivers, and pharma companies.

R&D

Life Sciences Industry Report - Rare Disease Space

There are some 7,000 known rare diseases in the world, yet, multiple challenges and unmet needs remain when it comes to therapies for these diseases.

R&D

Pharma holds it breath for ’25 as the sun shines on JP Morga...

The JP Morgan Healthcare Conference is seen as a barometer for the life sciences industry – and, going into this year’s event, the forecast for the year was particularly grim.

R&D

Six life sciences real estate trends to watch in 2025

Evolution and innovation are critical to the field of life sciences, with each year bringing new challenges and breakthroughs.

R&D

JP Morgan Week 2025 - Fabrizio Chines

In this video from JPM 2025, pharmaphorum chats with SIFI CEO and Chairman Fabrizio Chines about a new treatment for acanthamoeba keratitis.

R&D

Jennifer Schranz - pharmaphorum podcast Episode 162a

Rare disease and the women's health gap

For women with rare diseases, they often face a double jeopardy, where many of the symptoms they experience can be confused with and misdiagnosed.